Concepedia

Robert Szczepaniak‐Sloane

RS

19

Publications

8.7K

Citations

16

H-Index

2010

Active since

Affiliations

Cancer Research UK Manchester Institute(Current)

The Christie NHS Foundation Trust

The University of Texas MD Anderson Cancer Center

University of Manchester

AstraZeneca (United Kingdom)

Robert Szczepaniak‐Sloane is an author at Cancer Research UK Manchester Institute specializing in medicine, oncology, and tumor microenvironment.

ORCID

Top concepts

Publications per year

2010–2023

19

Publications

19

Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients

Vancheswaran Gopalakrishnan, Christine N. Spencer, Luigi Nezi et al. · Science · 2017 · 4.4K citations · Full text

Evaluation and Prognostic Significance of Circulating Tumor Cells in Patients With Non–Small-Cell Lung Cancer

Matthew Krebs, Robert Szczepaniak‐Sloane, Lynsey Priest et al. · Journal of Clinical Oncology · 2011 · 863 citations · Full text

Clinical Significance and Molecular Characteristics of Circulating Tumor Cells and Circulating Tumor Microemboli in Patients With Small-Cell Lung Cancer

Jian-Mei Hou, Matthew Krebs, Lee Lancashire et al. · Journal of Clinical Oncology · 2012 · 833 citations · Full text

Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response

Christine N. Spencer, Jennifer L. McQuade, Vancheswaran Gopalakrishnan et al. · Science · 2021 · 804 citations · Full text

, , +28

Analysis of Circulating Tumor Cells in Patients with Non-small Cell Lung Cancer Using Epithelial Marker-Dependent and -Independent Approaches

Matthew Krebs, Jianmei Hou, Robert Szczepaniak‐Sloane et al. · Journal of Thoracic Oncology · 2011 · 467 citations · Full text

, , +10

Rows per page

1–5 of 19